AI assistant
Sending…
INSMED Inc — Director's Dealing 2025
May 22, 2025
30150_dirs_2025-05-22_1d6291d3-ac6b-4b9a-9660-9d35dfb7454b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2025-05-20
Reporting Person: Desjardins Clarissa (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-05-20 | Common Stock | P | 1895 | $66.87 | Acquired | 1895 | Indirect |
| 2025-05-21 | Common Stock | P | 1130 | $66.35 | Acquired | 3025 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 67007 | Direct |
Footnotes
F1: This is the weighted average purchase price representing 1,895 shares purchased at prices ranging from $66.75 to $66.98 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares purchased at each price within the price range upon request.
More from INSMED Inc
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
Apr 7
Annual Report
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 19